Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2019

Ads

You May Also Like

PCI Biotech to present Phase I dose escalation results at ESMO

Oslo, Norway, 19 October 2018 — PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical ...

Interpace Diagnostics Announces Expansion into New Clinical Area with Launch of Molecular Lung Cancer Test

PARSIPPANY, N.J., Sept. 25, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” ...

BioTelemetry, Inc. Announces Its Latest Success in Patent Enforcement

MALVERN, Pa., July 20, 2016 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless ...